HEALTH Diseases

China Approves CARsgen CAR-T Treatment for Stomach Cancer

by admin on | 2026-06-22 14:25:02

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 64

China’s drug regulator has said on Monday it has approved a CARsgen Therapeutics treatment for stomach cancer, marking a new milestone for CAR-T therapies, which engineer patients’ immune cells to recognise and kill cancer cells.

The injection, also known as satri-cel, is the world’s first approved CAR-T cell therapy for solid tumors, CARsgen CEO Li Zonghai said in an interview after the announcement.

“So many patients are waiting for that,” Li said. CARsgen shares rose 6.8% on Monday.

CAR-T therapy is already used to treat blood cancers including leukemia, lymphoma and multiple myeloma. However, it is difficult for engineered cells to survive and function in the hostile microenvironment of a solid tumor, Li said.

Li added that CARsgen would likely disclose the price on Tuesday, and that the first patient would be dosed in at least three to four weeks. A couple of patients were already waiting for the drug, he said.

He said he expected about 200 orders for the drug in the second half of 2026.

REUTERS